PAN well over $100 and FEYE around 15.
Huge news for company and more to come.
In conjunction with the anticipated acquisition, MGT is pleased to announce the proposed appointment of Eric J. Anderson as Chief Technology Officer upon closing of the transaction. Mr. Anderson, who is well known as "Eijah" in the hacker community, is the founder of Demonsaw. For the past five years he was an Associate Technical Director and Lead Programmer for Rockstar Games where he architected core engine and artificial intelligence code for Grand Theft Auto, among the world's highest grossing video game franchises. Before that Eric was Lead Programmer for Guitar Hero 6 at Activision and also served as Portfolio Architect of Security at American Express. Eric has been a college faculty member, keynote speaker at DEF CON and Hack Miami conferences, and holds a Master's Degree in Computer Science from Arizona State University. He is an active member of the hacking community and is an avid proponent of Internet freedom.
Closing of the acquisition is contingent on customary conditions including approval by MGT's stockholders. Major terms of the deal include the payment to Demonsaw LLC members of 20.0 million restricted shares of MGT common stock. The proposed share issuance is expected to amount to approximately 28% of the Company's common stock on a pro-forma fully diluted basis at closing, inclusive of shares of common stock to be issued in connection with the Company's previously announced transaction with D-Vasive, Inc. More detailed information can be found in the Company's Form 8-K filed this morning with the Securities and Exchange Commission, available at www.sec.gov, or the MGT website at www.mgtci.com.
John McAfee, proposed Executive Chairman and Chief Executive Officer of MGT, stated, "Artificial intelligence will be crucial to the next generation of cybersecurity systems. Eijah's proposed appointment as Chief Technology Officer will cement our edge in the creation of cybersecurity products in this new paradigm of cyber threats."
Mr. McAfee, concluded with this comment, "I want to reiterate my personal commitment towards the creation of a major force in cybersecurity. As a listed company with proper corporate governance and regulatory standards, MGT will be the vehicle I use to create wealth for all stockholders."
By the end of the first half of 2016, ZYNE expects to report final
results from its ongoing Phase 1 single rising dose clinical trial,
including results from 12 patients with epilepsy.
-- By the end of the first half of 2016, ZYNE expects to report results
from its second ongoing Phase 1 multiple rising dose clinical trial
and soon imo.
Going higher imo.
The cancer cells retain the drug and the good cells eliminate it. $35 imo.
Investors made up to 15,000% last time with JM. I will risk $3 today.